TTO Legal Seminar: "Bench to Bedside: Oncology Drug Product Development and Target Commercialization"

The CU Technology Transfer Office and the law offices of Greenlee, Winner & Sullivan present the TTO Legal Seminar: "Bench to Bedside: Oncology Drug Product Development and Target Commercialization" with Eric Malek, Vice President of Business Development, Allos Theraputics.

Friday, April 29, 2005
Fitzsimmons Building 500
Summer Room, (R24-001)
Colfax and Ursula
Directions

12:00-2:00: Presentation and Discussion

*Seating Limited

Please R.S.V.P for lunch by 1pm Thursday April 28, 2005 to Elizabeth Towner: elizabeth.towner@uchsc.edu

Mr. Malek has served as Vice President, Corporate Development at Allos Theraputics since March 2003, and served as Senior Director, Corporate Development from March of 2002 to March 2003, and as Director, Corporate Development from June 2000 through March 2002. From 1994 to 2000, Mr. Malek held various positions in Corporate Development at NeXstar Pharmaceuticals, Gilead Sciences, Ilex Oncology and Research Corporation Technologies. Prior to that he worked in sales at Bio-Rad Laboratories and in research as an Associate with the Janssen Research Foundation as well as a Research Assistant at both University of Michigan's Protein Chemistry Facility and at the University of Arizona Department of Pharmacology. Mr. Malek received an M.B.A. in Finance and Marketing at the University of Michigan, and a B.A. in Biochemistry at the University of Arizona.